| Detected | Trial | Change |
|---|---|---|
| 2026-05-16 | NCT07244341 A Study of Valemetostat (DS-3201b) in Combination With Darolutamide in Metastatic… |
Trial sites expanded: 6 -> 19 locations |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 1/2 | |||
| NCT05683171 | A Phase 1/2, Open-label Study of Valemetostat in Combination With Rituximab and… | Lymphoma | Recruiting |
| NCT03930953 | A Safety and Preliminary Efficacy Study of CC-99282, Alone and in Combination With… | Lymphoma, Non-Hodgkin | Active, Not Recruiting |
| Phase 1 | |||
| NCT07244341 | A Study of Valemetostat (DS-3201b) in Combination With Darolutamide in Metastatic… | Metastatic Castration-resistant Prostate Cancer | Recruiting |
| NCT06807632 | A Study of Valemetostat in Combination With Atezolizumab in People With Lung Cancer | Extensive-stage Small-cell Lung Cancer | Recruiting |
| NCT05633979 | Phase 1b Study of EZH1/2 Inhibitor Valemetostat in Combination With Trastuzumab… | Breast Cancer | Active, Not Recruiting |
| NCT04388852 | DS3201 and Ipilimumab for the Treatment of Metastatic Prostate, Urothelial and Renal Cell… | Aggressive Variant Prostate Carcinoma | Active, Not Recruiting |